Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.
- Conditions
- SARS-CoV-2 Infection
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Laboratorio Avi-Mex, S.A. de C.V.
- Target Recruit Count
- 4065
- Registration Number
- NCT05710783
- Locations
- 🇲🇽
CAIMED Investigación en Salud S.A. de C.V., Mexico City, Cdmx, Mexico
🇲🇽Centro de Investigación Clínica Chapultepec S.A. de C.V., Coyoacán, Ciudad De México, Mexico
🇲🇽Unidad de Medicina Familiar No. 20 - IMSS, Gustavo A Madero, Ciudad De México, Mexico
Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence
- Conditions
- SARS CoV 2 Infection
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Laboratorio Avi-Mex, S.A. de C.V.
- Target Recruit Count
- 158
- Registration Number
- NCT05205746
- Locations
- 🇲🇽
Centro Mexicano de Estudios Clínicos CEMDEC SA de CV, Mexico City, Cdmx, Mexico
🇲🇽CAIMED Investigación en Salud S.A. de C.V., Mexico City, Cdmx, Mexico
🇲🇽Unidad Médico Familiar No. 20 Instituto Mexicano del Seguro Social, Mexico City, Cdmx, Mexico
Study of a Live rNDV Based Vaccine Against COVID-19
- Conditions
- SARS-CoV-2 Infection
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Laboratorio Avi-Mex, S.A. de C.V.
- Target Recruit Count
- 91
- Registration Number
- NCT04871737
- Locations
- 🇲🇽
Hospital Medica Sur, Mexico City, Ciudad De Mexico, Mexico